PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
33522985-8	2021	The blaOXA-48 gene was not detected.Well established antimicrobial agents such as colistin, gentamicin and tigecycline and novel antibiotics like ceftazidime/avibactam and eravacycline can be reliable options for the treatment of invasive infections caused by carbapenem-resistant K. pneumoniae.	eravacycline	172-184	OXA-48	Klebsiella pneumoniae	4-13
33063176-3	2020	In the concomitant administration with CYP 3A4-inducing drugs, eravacycline dosing should be modified.	eravacycline	63-75	cytochrome P450 family 3 subfamily A member 4	Homo sapiens	39-46
30068997-5	2018	This study identified 67 eravacycline-nonsusceptible isolates; among the extended-spectrum beta-lactamase (ESBL)-positive isolates, eravacycline-nonsusceptible isolates were detected more frequently than tigecycline-nonsusceptible isolates (21.7% vs. 9.4%, p = 0.001).	eravacycline	25-37	CTX-M-15	Klebsiella pneumoniae	73-105
30068997-5	2018	This study identified 67 eravacycline-nonsusceptible isolates; among the extended-spectrum beta-lactamase (ESBL)-positive isolates, eravacycline-nonsusceptible isolates were detected more frequently than tigecycline-nonsusceptible isolates (21.7% vs. 9.4%, p = 0.001).	eravacycline	132-144	CTX-M-15	Klebsiella pneumoniae	73-105
26863149-1	2016	Eravacycline is an investigational, synthetic fluorocycline antibacterial agent that is structurally similar to tigecycline with two modifications to the D-ring of its tetracycline core: a fluorine atom replaces the dimethylamine moiety at C-7 and a pyrrolidinoacetamido group replaces the 2-tertiary-butyl glycylamido at C-9.	eravacycline	0-12	complement component 7	Mus musculus	240-243
26863149-1	2016	Eravacycline is an investigational, synthetic fluorocycline antibacterial agent that is structurally similar to tigecycline with two modifications to the D-ring of its tetracycline core: a fluorine atom replaces the dimethylamine moiety at C-7 and a pyrrolidinoacetamido group replaces the 2-tertiary-butyl glycylamido at C-9.	eravacycline	0-12	complement component 9	Mus musculus	322-325